LIFESIGN, CARE POINT, VITALSIGN, ACCUSIGN— 510(k) K944325

Name: FDA 510(k) clearance K944325
Creator: U.S. Food and Drug Administration
Published: 1995-02-22

Substantially Equivalent

Princeton BioMeditech Corp.

FDA 510(k) clearance K944325 for LIFESIGN, CARE POINT, VITALSIGN, ACCUSIGN, Substantially Equivalent on 1995-02-22. Applicant: Princeton BioMeditech Corp.. Device class: 2.

Clearance details

Applicant: Princeton BioMeditech Corp.
Product code: Code JHW
Device class: Class 2
Regulation: 21 CFR 862.1215
Advisory panel: Clinical Chemistry
Date received: 1994-09-02
Decision date: 1995-02-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JHW

view all

K162526 — Creatine Kinase-MB2017-05-26
K141265 — ELITECH CLINICAL SYSTEMS ENVOY 500 CK REAGENT KIT2014-07-18
K122083 — ELITECH CLINICAL SYSTEMS CK NAC SL2012-08-22
K023744 — WIENER LAB. CK-MB DS UV UNITEST, MODEL 28 X 2.5 ML CAT. NR. 12713542003-01-03
K003158 — ROCHE DIAGNOSTICS CK-MB2000-12-18

More clearances from Princeton BioMeditech Corp.

view all

K251538 — Status COVID-19/Flu A&B2025-11-14
K182157 — BioSign Flu A+B2018-09-18
K130650 — STATUS DS OXY2014-02-26
K133474 — BIOSIGN FLU A + B, STATUS FLU A & B2013-12-10
K132465 — BIOSIGN FLU A + B, STATUS FLU A & B2013-09-09

Data sourced from openFDA. This site is unofficial and independent of the FDA.